Long-term patency of small-diameter vascular graft made from fibroin, a silk-based biodegradable material

Journal of Vascular Surgery

Volumn 51, Issue 1, 2010, Pages 155-164

  Enomoto, Soichiro ^a   Sumi, Makoto ^a,b   Kajimoto, Kan ^c   Nakazawa, Yasumoto ^d   Takahashi, Rui ^d   Takabayashi, Chiyuki ^e   Asakura, Tetsuo ^d   Sata, Masataka ^f  

^a UNIVERSITY OF TOKYO   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^e NATIONAL INSTITUTE OF AGROBIOLOGICAL SCIENCES   (Japan)

^f UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD31 ANTIGEN; COLLAGEN; GREEN FLUORESCENT PROTEIN; HEPARIN; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE; SILK FIBROIN;

ANGIOGRAPHY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABLE IMPLANT; BLOOD VESSEL GRAFT; BONE MARROW TRANSPLANTATION; CELL CULTURE; CELL MIGRATION; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DESCENDING AORTA SURGERY; END TO END ANASTOMOSIS; ENDOTHELIUM CELL; FLOW CYTOMETRY; FLUOROSCOPY; GRAFT PATENCY; GRAFT PERFUSION; HISTOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LONG TERM CARE; MALE; NONHUMAN; POLITEF IMPLANT; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; SMALL DIAMETER SILK FIBROIN VASCULAR GRAFT; SMOOTH MUSCLE FIBER; SPRAGUE DAWLEY RAT; TISSUE ENGINEERING; TRANSGENIC RAT;

ABSORBABLE IMPLANTS; ACTINS; ANIMALS; ANTIGENS, CD31; AORTA, ABDOMINAL; AORTOGRAPHY; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL MOVEMENT; COLLAGEN; ENDOTHELIAL CELLS; FIBROINS; GREEN FLUORESCENT PROTEINS; MALE; MATERIALS TESTING; MODELS, ANIMAL; MYOCYTES, SMOOTH MUSCLE; POLYTETRAFLUOROETHYLENE; PROSTHESIS DESIGN; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; TIME FACTORS; ULTRASONOGRAPHY, DOPPLER, COLOR; VASCULAR PATENCY;

EID: 72549100121     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2009.09.005     Document Type: Article

References (38)

1. Pektok E., Nottelet B., Tille J.C., Gurny R., Kalangos A., Moeller M., et al. Degradation and healing characteristics of small-diameter poly(epsilon-caprolactone) vascular grafts in the rat systemic arterial circulation. Circulation 118 (2008) 2563-2570
2. Daenens K., Schepers S., Fourneau I., Houthoofd S., and Nevelsteen A. Heparin-bonded ePTFE grafts compared with vein grafts in femoropopliteal and femorocrural bypasses: 1- and 2-year results. J Vasc Surg 49 (2009) 1210-1216
3. Pawlowski K.J., Rittgers S.E., Schmidt S.P., and Bowlin G.L. Endothelial cell seeding of polymeric vascular grafts. Front Biosci 9 (2004) 1412-1421
4. Langer R., and Vacanti J.P. Tissue engineering. Science 260 (1993) 920-926
5. Sharp M.A., Phillips D., Roberts I., and Hands L. A cautionary case: the SynerGraft vascular prosthesis. Eur J Vasc Endovasc Surg 27 (2004) 42-44
6. Shin'oka T., Matsumura G., Hibino N., Naito Y., Watanabe M., Konuma T., et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 129 (2005) 1330-1338
7. L'Heureux N., Dusserre N., Konig G., Victor B., Keire P., Wight T.N., et al. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 12 (2006) 361-365
8. L'Heureux N., McAllister T.N., and de la Fuente L.M. Tissue-engineered blood vessel for adult arterial revascularization. N Engl J Med 357 (2007) 1451-1453
9. McAllister T.N., Maruszewski M., Garrido S.A., Wystrychowski W., Dusserre N., Marini A., et al. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet 373 (2009) 1440-1446
10. Altman G.H., Diaz F., Jakuba C., Calabro T., Horan R.L., Chen J., et al. Silk-based biomaterials. Biomaterials 24 (2003) 401-416
11. Lam K.H., Nijenhuis A.J., Bartels H., Postema A.R., Jonkman M.F., Pennings A.J., et al. Reinforced poly(L-lactic acid) fibres as suture material. J Appl Biomater 6 (1995) 191-197
12. Rossitch Jr. E., Bullard D.E., and Oakes W.J. Delayed foreign-body reaction to silk sutures in pediatric neurosurgical patients. Childs Nerv Syst 3 (1987) 375-378
13. Salthouse T.N., Matlaga B.F., and Wykoff M.H. Comparative tissue response to six suture materials in rabbit cornea, sclera, and ocular muscle. Am J Ophthalmol 84 (1977) 224-233
14. Soong H.K., and Kenyon K.R. Adverse reactions to virgin silk sutures in cataract surgery. Ophthalmology 91 (1984) 479-483
15. Altman G.H., Horan R.L., Lu H.H., Moreau J., Martin I., Richmond J.C., et al. Silk matrix for tissue engineered anterior cruciate ligaments. Biomaterials 23 (2002) 4131-4141
16. Inouye K., Kurokawa M., Nishikawa S., and Tsukada M. Use of Bombyx mori silk fibroin as a substratum for cultivation of animal cells. J Biochem Biophys Methods 37 (1998) 159-164
17. Minoura N., Aiba S., Gotoh Y., Tsukada M., and Imai Y. Attachment and growth of cultured fibroblast cells on silk protein matrices. J Biomed Mater Res 29 (1995) 1215-1221
18. Sofia S., McCarthy M.B., Gronowicz G., and Kaplan D.L. Functionalized silk-based biomaterials for bone formation. J Biomed Mater Res 54 (2001) 139-148
19. Okabe M., Ikawa M., Kominami K., Nakanishi T., and Nishimune Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett 407 (1997) 313-319
20. Sata M., Saiura A., Kunisato A., Tojo A., Okada S., Tokuhisa T., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 8 (2002) 403-409
21. Fukuda D., Sata M., Ishizaka N., and Nagai R. Critical role of bone marrow angiotensin II type 1 receptor in the pathogenesis of atherosclerosis in apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol 28 (2008) 90-96
22. Tanaka K., Sata M., Hirata Y., and Nagai R. Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ Res 93 (2003) 783-790
23. Sahara M., Sata M., Morita T., Nakamura K., Hirata Y., and Nagai R. Diverse contribution of bone marrow-derived cells to vascular remodeling associated with pulmonary arterial hypertension and arterial neointimal formation. Circulation 115 (2007) 509-517
24. Grzesiak J.J., Pierschbacher M.D., Amodeo M.F., Malaney T.I., and Glass J.R. Enhancement of cell interactions with collagen/glycosaminoglycan matrices by RGD derivatization. Biomaterials 18 (1997) 1625-1632
25. He H., Shirota T., Yasui H., and Matsuda T. Canine endothelial progenitor cell-lined hybrid vascular graft with nonthrombogenic potential. J Thorac Cardiovasc Surg 126 (2003) 455-464
26. Kaushal S., Amiel G.E., Guleserian K.J., Shapira O.M., Perry T., Sutherland F.W., et al. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 7 (2001) 1035-1040
27. Matsumura G., Hibino N., Ikada Y., Kurosawa H., and Shin'oka T. Successful application of tissue engineered vascular autografts: clinical experience. Biomaterials 24 (2003) 2303-2308
28. Moriya M., Roschzttardtz F., Nakahara Y., Saito H., Masubuchi Y., and Asakura T. Rheological properties of native silk fibroins from domestic and wild silkworms, and flow analysis in each spinneret by a finite element method. Biomacromolecules 10 (2009) 929-935
29. Zhao C., Yao J., Masuda H., Kishore R., and Asakura T. Structural characterization and artificial fiber formation of Bombyx mori silk fibroin in hexafluoro-iso-propanol solvent system. Biopolymers 69 (2003) 253-259
30. Setzen G., and Williams III E.F. Tissue response to suture materials implanted subcutaneously in a rabbit model. Plast Reconstr Surg 100 (1997) 1788-1795
31. Bucknall T.E., Teare L., and Ellis H. The choice of a suture to close abdominal incisions. Eur Surg Res 15 (1983) 59-66
32. Sahara M., Sata M., Matsuzaki Y., Tanaka K., Morita T., Hirata Y., et al. Comparison of various bone marrow fractions in the ability to participate in vascular remodeling after mechanical injury. Stem Cells 23 (2005) 874-878
33. Hillebrands J.L., Klatter F.A., van Dijk W.D., and Rozing J. Bone marrow does not contribute substantially to endothelial-cell replacement in transplant arteriosclerosis. Nat Med 8 (2002) 194-195
34. Hu Y., Davison F., Ludewig B., Erdel M., Mayr M., Url M., et al. Smooth muscle cells in transplant atherosclerotic lesions are originated from recipients, but not bone marrow progenitor cells. Circulation 106 (2002) 1834-1839
35. Fukuda D., Sata M., Tanaka K., and Nagai R. Potent inhibitory effect of sirolimus on circulating vascular progenitor cells. Circulation 111 (2005) 926-931
36. Simper D., Stalboerger P.G., Panetta C.J., Wang S., and Caplice N.M. Smooth muscle progenitor cells in human blood. Circulation 106 (2002) 1199-1204
37. Bocan T.M. Animal models of atherosclerosis and interpretation of drug intervention studies. Curr Pharm Des 4 (1998) 37-52
38. Torikai K., Ichikawa H., Hirakawa K., Matsumiya G., Kuratani T., Iwai S., et al. A self-renewing, tissue-engineered vascular graft for arterial reconstruction. J Thorac Cardiovasc Surg 136 (2008) 37-45 e1